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The thermal aggregation of the biopharmaceutical protein recombinant protective antigen (rPA) has been explored, and the
associated kinetics and thermodynamic parameters have been extracted using optical and environmental scanning electron
microscopies (ESEMs) and ultraviolet light scattering spectroscopy (UV-LSS). Visual observations and turbidity measurements
provided an overall picture of the aggregation process, suggesting a two-step mechanism. Microscopy was used to examine the
structure of aggregates, revealing an open morphology formed by the clustering of the microscopic aggregate particles. UV-LSS
was used and developed to elucidate the growth rate of these particles, which formed in the first stage of the aggregation process.
Their growth rate is observed to be high initially, before falling to converge on a final size that correlates with the ESEM data.
The results suggest that the particle growth rate is limited by rPA monomer concentration, and by obtaining data over a range
of incubation temperatures, an approach was developed to model the aggregation kinetics and extract the rate constants and the
temperature dependence of aggregation. In doing so, we quantified the susceptibility of rPA aggregation under different temperature
and environmental conditions and moreover demonstrated a novel use of UV spectrometry to monitor the particle aggregation
quantitatively, in situ, in a nondestructive and time-resolved manner.
1. Introduction
The study of protein aggregation is a burgeoning field of re-
search driven by the urgent need to elucidate the mech-
anism of neurodegenerative diseases, the desire to under-
stand and mimic natures’ ability to create hierarchical com-
plex nanostructures, and the necessity to understand and
minimise product loss during the processing and formu-
lation of biopharmaceuticals. Aggregation is of particular
importance for therapeutic proteins as it can lead to a
loss of product, reduce efficacy, alter biological activity and
pharmacokinetics, and even raise safety concerns such as
increased immunogenicity [1–3]. Aggregation can be induced
by solution conditions such as protein concentration, pH,
salinity, temperature, and the presence of additives [4, 5].
These variables are also known to affect the quantity and
morphology of aggregate formed [5]. Stresses to the protein
such as over-expression, refolding, freeze-thaw cycles, agita-
tion, or exposure to hydrophobic surfaces or air (including
foaming) can also lead to the formation of aggregates [2, 4–6].
Each of these environmental factors is typically encountered
during bioprocessing, downstream processing, storage, and
also during and after in vivo delivery of biopharmaceutical
actives. Hence, there is significant on going work channelled
into exploring the onset of aggregation and the aggregation
pathway. Understanding these factors subsequently allows
the development of an informed strategy to minimise aggre-
gation during biopharmaceutical production, for example,
the inclusion of surfactants to influence protein monomer
interactions.
The influence of solution pH on aggregation is one of
the more studied and important parameters that controls
the onset of aggregation and final aggregate morphology [5].
This is because pH alters the surface charge of the protein
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monomer and also the extent of any structural disruption
prior to aggregation, and hence influences their propensity
to self-assemble and the manner in which they go onto
aggregate. For example, at pH values close to the isoelectric
point, repulsive interactions between native monomers are
reduced, making assembly more favourable. Under these
conditions, particulates typically form [7]. At pHs far from
the isoelectric point, increased charge repulsion within the
protein destabilises the folded conformation, leading to the
exposure of hydrophobic groups, which in turn can drive the
self-assembly of these unfolded states, typically into 𝛽-sheet
rich fibrillar structures [8, 9]. Temperature is another key
factor, if not the most critical factor in commercial processes
that induces aggregation, where increasing the temperature
increases the vibrational motion and diffusion of proteins
which is a necessary step for aggregation. Moreover, as
the temperature nears the denaturation temperature of the
protein, the protein partially unfolds, exposing hydrophobic
regions, which induces aggregation [10].
The literature is awash with many studies that postu-
late different models for the self-assembly of proteins, and
these can generally be divided into two main categories:
empirical or mechanistic [11]. Mechanistic models are based
on a reaction scheme and have parameters relating to the
kinetics/thermodynamics of the process, whereas empirical
models utilise functions that fit the data but have no physical
meaning. A large array of different mechanistic models have
been proposed, and these have been broadly categorised as
monomer addition, reversible association, prion aggregation,
minimalistic 2-step, or quantitative structure-activity rela-
tionships [11]. Alternatively, Roberts proposed a comprehen-
sive generic mechanistic scheme for protein aggregation with
associated generic equations, and he went onto show how
these could be simplified for certain conditions and limiting
cases [12]. Overall, most of these models are based on the
idea of aggregation beingmediated by a reactive intermediate
which is in equilibriumwith the native state; the intermediate
is able to aggregate, initially via a nucleation step followed by
a growth phase, that is, Native (N) ↔ Intermediate (I) →
Aggregate (A). Many groups have experimentally tested such
models, and techniques have been developed and exploited to
study aggregation both ex situ and in situ [13, 14]. In ex situ,
the state of aggregation is measured in static samples, where
long data acquisition times are needed, or samples need to
be separated, dried, fixed or labelled, for example, using
electron microscopy or mass spectrometry. Furthermore, the
aggregation process has to be reliably halted and persevered
for a series of samples representing different stages. In in
situ measurements, aggregation events are monitored as
they happen, but the technique used needs sufficient time
resolution for the process being monitored and the data
analysis can be complex, since there is typically a mixture of
component sizes, that is, aggregates and monomers. Typical
techniques currently used include circular dichroism, Fourier
transform infra-red, and dynamic light scattering [13, 15]. For
a technique to yield useful information about the aggregation
process, it is crucial to be able to relate the measured
parameter back to changes in the aggregation state such as
aggregate size or monomer depletion.
Here, the thermal aggregation of an industrially relevant
biopharmaceutical recombinant protective antigen (rPA)
(active component in a second-generation anthrax vaccine
[16]) has been examined visually and via turbidity measure-
ments, before information on the size and the shape of the
aggregates formed were obtained using a combination of
optical and environmental scanning electron microscopies.
Two environmental conditions were explored, where samples
were prepared with and without the denaturant urea. Subse-
quently, the rate of aggregate growth at different isothermal
temperatures was compared using ultraviolet light scattering
spectroscopy (UV-LSS) [17–23], with particle size being
extracted as a function of time. This was done by collecting
spectra over time without the need to remove material
for analysis, hence demonstrating a nondestructive, in situ,
and time-resolved method for monitoring the aggregation
process. Results for the aggregation of rPA will be discussed,
and a model describing the kinetics and thermodynamics of
aggregation is presented.
2. Materials and Methods
2.1. Materials. rPA was supplied by Avecia Biologics (UK) at
2mgmL−1 in a phosphate-buffered saline solution adjusted
to pH 7.4. Doubly distilled water was obtained from an Elga
PureLab Ultra (18.2Ω). All other chemicals were purchased
from either Sigma-Aldrich (UK) or Acros Organics (UK),
where the reagent grade is at least 97% pure and used as
recieved.
2.2. Sample Preparation. The rPA samples supplied were
treated using the following procedure to provide a consistent
starting material for analysis. Initially, rPA was precipitated
from solution by heating (50∘C for circa 5min).The resulting
gel was centrifuged at 6000 rpm for 1 minute, and the super-
natant was discarded. The gel was resuspended by adding
doubly distilled water and vortexing for 2min. The sample
was centrifuged as before, and the supernatant was discarded.
The gel was resolubilized by adding urea and doubly distilled
water to form an 8M urea solution. rPA was refolded by
dilution, using 1 part rPA in 8M urea to 31 parts refold buffer.
This was done in two stages, with a 1 : 7 dilution followed
by 1 : 4 dilution 2 minutes later. The refold buffer contained
25mM TRIS, 25mM NaCl, 2mM CaCl
2
and was adjusted
to pH 7.4 with hydrochloric acid. The final buffered samples
contained between circa 0.15 and 0.3mgmL−1 rPA with
0.25M urea and were analysed immediately after refolding.
This concentration was chosen as it mimics the conditions
of storage of some of the formulations of protective antigen
vaccines. Samples without urea were prepared using the
refolding method followed by dialysis using 3500 Dalton
molecular weight cutoffVisking dialysismembrane (Medicell
International Ltd) against 10 times excess of chilled refold
buffer for 18 hours in the refrigerator (∼4∘C). After this,
the external solution was replaced twice with fresh refold
buffer and allowed to dialyse for a further 24 hours. The rPA
sample was then recovered from the sealed membrane and
stored in the refrigerator (circa 4∘C) prior to use. This was
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done to reduce any degradation of the rPA during storage.
Samples, however, were not frozen to avoid potential freeze-
thaw damage.
2.3. Concentration Analysis. The concentration of the refold-
ed rPA solution was determined from its UV absorbance at
280 nm (Shimadzu UV 2501-PC spectrophotometer), using a
molar absorption coefficient of 72769M−1 cm−1.
2.4. Visual Observations. The isothermal aggregation of rPA
was monitored visually over time by incubating samples over
a range of temperatures (43–49∘C) close to the denaturation
temperature of rPA (50.0∘C) by using a recirculating water
bath connected to a heating stage that contained the sample
cell.The temperature wasmeasured using a calibrated K-type
thermocouple placed in the sample solution (accurate to ±
0.3∘C).
2.5. Optical Microscopy. Images of rPA aggregates were
obtained using a Zeiss Axioplan 2 in transmission mode
with a 10x magnification objective and a digital camera. The
aggregated sampleswere pipetted onto amicroscope slide and
a cover slip placed on top.
2.6. Environmental Scanning Electron Microscopy (ESEM).
Aggregates weremounted for ESEM analysis simply by lifting
them out of solution on a mica disc and placing them
directly onto the sample stage. The samples were examined
using a Philips FEI Quanta 200 ESEM with the electron gun
accelerating voltage set to 30 kV, the sample stage at 5∘C, and
the chamber pressure at 6 torr.
2.7. Light Scattering. Light scattering spectra were recorded
using a Shimadzu UV 2501-PC spectrophotometer set to
record between 250 and 390 nm every 2 nm at amedium scan
rate. The sample was heated in-situ as previously described.
2.8. Theory. The wavelength dependence of absorbance aris-
ing from light scattering by particles in solution follows the
relationship [24]
𝐴
𝜆
= 𝛼𝜆−𝛽, (1)
where 𝐴
𝜆
is the absorbance at wavelength 𝜆, 𝛼 is a constant
and 𝛽 is the scattering exponent. The scattering exponent
can be related to particle size using Mie theory. Here,
the Mie equations were solved over a range of particle
sizes (nanometres to micrometres) for wavelengths between
320 and 390 nm using a FORTRAN programme adapted
from Bohren and Huffman [24]. These calculations required
the refractive index of the particles and the surrounding
solution for all relevant wavelengths. The solution refractive
index was taken to be that of water [25] and the particle
refractive index was calculated by evaluating the Lorentz-
Lorenz molar refraction [26] using the chemical formula
of rPA and a density of 1.43 g cm−3. The density was based
on the molecular weight of rPA (82667Da) and its volume
(95.74 nm3) as calculated by VADAR [27] using the crystal
Table 1: Refractive index of rPA particles at different wavelengths
calculated using the Lorentz-Lorenz molar refraction.
Wavelength/nm Refractive index, 𝑛
434.0 1.684
486.1 1.677
589.3 1.665
656.3 1.661
structure of rPA [28], which is stored in the protein data bank
(http://www.pdb.org/) [29] under PDB ID : 1ACC.This value
of density was considered reasonable compared to the density
of other proteins with a similar molecular weight [30]. The
values of refractive index, 𝑛, calculated for the particles at
different wavelengths, 𝜆, within the visible region are given
in Table 1.These values were subsequently extrapolated to the
UV region using the Cauchy equation [26];
𝑛 = 1.642 +
7980
𝜆2
. (2)
The results obtained using Mie theory were analysed to give
a theoretical scattering exponent versus diameter, providing
a means of converting experimental scattering exponents to
particle size:
𝑑 = − 0.686 𝛽6 + 6.869 𝛽5 − 21.397 𝛽4 + 23.795 𝛽3
− 23.682 𝛽2 − 111.896 𝛽 + 642.207,
(3)
where 𝑑 is the particle diameter (nm) and 𝛽 is the scattering
exponent between 320 and 390 nm.
3. Results and Analysis
3.1. Qualitative Aggregation. Solutions of rPA (0.31mgmL−1)
were incubated over a range of temperatures (25–50∘C), and
their visual appearance was monitored over time. This tem-
perature range was selected as the denaturation temperature
of rPA is known to be ∼50∘C [31]. Sample appearance was
observed to change when the temperature increased above
∼43∘C. A typical example of these changes is recorded in
Figure 1, which shows the visual appearance of rPA in solution
over time whilst held at a steady temperature of 47.6∘C.
Initially, the sample was clear, as can be seen from Figure 1(a),
and remained clear over the first few minutes. After 8 min-
utes, the sample started to become cloudy, which is evident in
Figure 1(b). The slightly cloudy homogeneous appearance of
the sample indicates the presence of microscopic particles of
sufficient size and concentration to noticeably scatter visible
light. Such behaviour is indicative of the aggregation of
rPA. Over the minutes that followed, the sample remained
homogeneous but gradually became more turbid, suggesting
further aggregation. This can be seen by comparing the
images in Figures 1(b) and 1(c); the latter appears cloudier.
After 32 minutes, the sample was no longer homogeneous,
since particles large enough to be observed visually started
to form (see Figure 1(e)). From this point forwards, the black
background was removed to provide improved contrast for
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observing the macroscopic particles that were forming in the
solution; the sample remained cloudy but appeared brighter,
since light was able to enter from behind. The macroscopic
particles were more easily observed and appeared as dark
spots against the bright cloudy solution. Following their
emergence, the macroscopic particles were observed initially
to increase in size and number as can be seen from the
images shown in Figures 1(e) and 1(f). Beyond this point,
the number of individual particles appeared to fall whilst
continuing to grow in size (Figure 1(g)). This observation
suggests that the particles grew by clustering together. The
final image of the sample, Figure 1(h), was taken with the
black background replaced to enable comparison with the
initial sample appearance. It shows that the sample had
returned to a clear solution apart from the presence of large
white particles, some of which had settled on the bottom
and the sides of the cuvette. Such observations suggest that
small microscopic particles form initially, causing the sample
to appear turbid, and subsequently cluster to form large
macroscopic particles that sediment due to gravity when they
are above a critical size.
These visual results were complemented by turbidity
measurements recorded under identical conditions (see Fig-
ure 2); the labels (“a” to “h”) in Figure 2 are positioned to
relate to the photographs taken of rPA aggregation shown in
Figure 1. The turbidity was assessed by recording the optical
density using light with a wavelength of 320 nm. Figure 2
shows a sharp rise in turbidity over the first 20 minutes
of incubation. This is consistent with the appearance and
growth of particles in the solution, as indicated by the visual
observations. The subsequent fall in turbidity suggests that
the particles were either decreasing in size (which might
occur if the aggregation was reversible) or decreasing in
concentration (which could occur if the particles clustered
to form larger structures). The latter is consistent with our
visual observation of particles growing in size and reducing in
number over time, before settling to the bottom of the sample
cuvette.
Similar visual and turbidity observations were noted
for other samples incubated between 43∘ and 49∘C, as all
appeared to have a similar two-step mechanism. The time
scales for each step varied widely; however, for the different
temperatures, the time to reach peak turbidity ranged from
circa 10 minutes at 49∘C to 10 hours at 43∘C. This dramatic
increase in aggregation rate versus temperature could be
driven by either increasing the translational kinetic energy of
proteinmonomers, causingmore frequent collisions between
the particles, or increasing the internal kinetic energy of the
proteinmonomers.The latter will drivemonomers toward an
unfolded state, with the associated exposure of hydrophobic
patches increasing the likelihood that a collision results in
self-association.
3.2. Aggregate Morphology. The morphology of the macro-
scopic particles formed after incubation was examined using
optical and electron microscopy. Figure 3(a) shows a typical
optical micrograph of the rPA aggregates formed after 16
hours at 47∘C. The micrograph reveals the formation of
several aggregates with different shapes and sizes, but all
appear to be composed of microscopic particles. This is
consistent with the visual observation of a cloudy solution of
microscopic particles which cluster to form large aggregates.
The aggregates generally range in length from ∼75 to 730 𝜇m
and have a width of ∼5–150𝜇m. Three aggregates with
fairly distinct structures have been labelled 𝛼, 𝛽, and 𝛾 in
Figure 3(a). The smallest, labelled 𝛼, is 165 𝜇m long and
30 𝜇m at its widest point. This aggregate appears reasonably
linear with growth predominantly in one direction with
limited side branching. The other two aggregates, 𝛽 and 𝛾,
are larger and have similar dimensions: ∼380 𝜇m by 150 𝜇m.
However, 𝛾 has a very dense structure, whilst 𝛽 has a
more open structure. The open structure of 𝛽 consists of a
branched system of linear components similar to aggregate
𝛼, suggesting that 𝛼 is a precursor to the formation of 𝛽:
either as one of many components that come together or as
the starting point for further growth or a combination of
both. The structure of 𝛾 is densely packed; however, there
is still some evidence of a branched structure and these are
similar to the structural features observed in 𝛽. Suggesting
that 𝛽 is possibly a precursor to the formation of 𝛾. Such
observations and inferences are also supported by previous
work on fractal aggregates, reviewed by Meakin [32]. Such
comparisons suggest that the rPA aggregates described here
are fractal aggregates, confirming that they are formed by
the clustering of microscopic particles. To obtain further
information on the size and the shape of the microscopic
particles, the aggregates were viewed under ESEM and a
typical micrograph is given in Figure 3(b). The microscopic
particles appeared reasonably spherical and uniform with
a diameter of approximately 500 nm. This observation is
consistentwith the previously reported results for the thermal
aggregation of proteins close to their isoelectric points, which
showed the formation ofmonodisperse particulates [7]. Here,
we areworking at pH7.4, which is close to the isoelectric point
of rPA (pH 5.6) [16]; therefore, individual protein monomers
will have reduced net charge. In addition, the salt present
in the buffered media will screen any remaining charge on
the proteins, thus any long-range charge-charge repulsions
which could act as a barrier to aggregation will have been
minimised. The protein monomer is likely to be partially
unfolded as the temperature approaches the denaturation
temperature (∼50∘C). The exposed hydrophobic regions will
consequently drive nonspecific monomer aggregation under
these conditions of reduced net charge. This in turn leads to
the formation of the three-dimensional spherical aggregates,
as observed in Figure 3(b).The approximately uniform size of
the particles in each sample suggests that their concentration
remained reasonably constant during their growth which
is consistent with the features of protein aggregation sum-
marised by Gosal and Ross-Murphy [10]. A slight increase
in particle diameter from 360 to 500 nm was noted as the
incubation temperature increased from 43 to 49∘C.
3.3. Particle Growth Rate. The rate of aggregation at different
isothermal temperatures was explored using UV light scat-
tering spectroscopy (UV-LSS), where spectra were recorded
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(a)
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(b)
?????
(c)
32 min
(d)
36 min
(e)
41 min
(f)
51 min
(g)
62 min
(h)
Figure 1: Photographs taken at different time points of rPA aggregates forming in solution at 47.6∘C. Note that each of (a) to (c) and (h) has
a black background placed behind the cuvette and (d) to (g) have no background allowing light to enter the sample from behind.
every 20 seconds initially and then every 20 seconds to
40 minutes depending on the aggregation rate. Such fast
acquisition times provide a speed advantage over other
light scattering techniques for analysing such aggregation
kinetics. Typical results for incubation at 45∘C are shown in
Figure 4(a). It is clear that there was no absorbance initially
(no chromophores in the protein absorb over this wavelength
range), but the absorbance intensity increases over time,
where the difference between successive spectra is large ini-
tially but reduces over longer times. Minimal difference was
observed after ∼200 minutes.This implies that the aggregates
grew quickly initially when the rPA monomer concentration
was at its highest, followed by slowing growth as the rPA
monomers were consumed and falling in concentration.This
suggests that the particle growth rate is limited by rPA
monomer concentration.
As discussed previously, rPA solutions became turbid
during incubation at temperatures ≥43∘C; therefore, it can be
assumed thatmultiple light scatteringwas occurring. It can be
assumed, however, that the wavelength dependence of light
scattering obtained by solving the Mie equations would hold
for the scattering occurring here. As such, the UV spectra in
Figure 4(a) were analysed (see Section 2.8) to give aggregate
diameter versus time; see Figure 4(b). It is clear that the par-
ticles grew quickly over the initial ∼60min before gradually
slowing and reaching a final particle size after ∼300min at
this temperature. The equilibrium sizes of particles formed
increased slightly from 390 to 500 nm with increasing the
incubation temperature, which correlates well with the ESEM
observations (∼360–500 nm). This confirms our assumption
that the wavelength dependence of light scattering in a turbid
solution can be adequately approximated by Mie theory.
To explore the effect of isothermal temperature on par-
ticle growth rate and consequently gain an insight into the
aggregation kinetics, particle size was recorded as a function
of time for a range of temperatures (43∘–49∘C) and the results
are given in Figure 5. The aggregate diameter versus time
profile was fitted with
𝑑model = 𝑑𝑓 − 𝑑0 ⋅ 𝑒
−𝑡/𝜏, (4)
where 𝑑model is the model fit to the particle diameter (nm),
𝑑
𝑓
is the final particle diameter that the function converges
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Figure 2: Absorbance at 320 nm versus time for rPA held at 47.7∘C
(×). Labels “a” to “h” relate to the photographs shown in Figure 1.
on (nm), 𝑑
0
is a fitting parameter (nm), 𝜏 is a time constant
for the particle growth process (s), and 𝑡 is time (s). The
optimum fit was found using Newton’s method to maximise
the correlation coefficient, 𝑅2, whilst allowing the value of
𝑑
𝑓
to vary. The values of 𝑑
0
, 𝜏, and correlation coefficient
were calculated from a straight line fit (using least squares
regression) to a plot of ln(𝑑
𝑓
−𝑑model) versus time.Themodel
fit for each run is included in Figure 5.
All profiles show an increase in diameter over time;
however, the time taken to reach the maximum diameter
is markedly different for each temperature: the higher the
temperature, the shorter the time scale to reach themaximum
diameter. This is reflected in the results by a notable increase
in the profile gradient when the temperature is increased,
where the maximum gradient increases by 2.7 times on
average for every 1∘C increase in temperature. Similar results
were obtained for a range of samples containing an additive:
0.25M urea. In this case, similar trends were observed over
time for a range of incubation temperatures, and the only
difference arising was in the rate of particle growth being
slightly faster for each sample in the presence of 0.25M
urea. All samples contained a homogeneous distribution
of particle size (confirmed by ESEM) suggesting that the
aggregate concentration remained constant over time. This
means that the quantity of rPA in the aggregates can be
determined by estimating the aggregate concentration and
using the ratio of aggregate to monomer volume. From this,
the difference between the quantity of rPA incorporated
within aggregates and the quantity of monomer present
initially gave monomer concentration over time, providing a
possible means of assessing the aggregation kinetics. To this
end, data over initial incubation times (where the scattering
was increasing) were analysed using a generalised scheme of
the protein aggregation pathway. This scheme is outlined in
Figure 6, where𝑁 is the native state, 𝐼 is the proteinmonomer
in an intermediate (unfolded or denatured) conformational
state, 𝐴
𝑗
is an aggregate consisting of 𝑗 protein molecules,
(𝐴
𝑚
)
𝑛
is a cluster of particulate aggregates, and 𝑘
1
to 𝑘
5
are
the rate constants for the different processes.This aggregation
pathway can be simplified based on the aforementioned
experimental observations; it was considered reasonable to
exclude step d, since the spherical nature of the aggregates
inferred that their growth was dominated by single monomer
addition rather than clustering to form irregular structures,
and step bwas also considered not to have played a significant
role, since the aggregates formed were reasonably uniform in
size, for which the aggregate concentrationwould have had to
be reasonably constant during their growth. It is reasonable
to expect that if new aggregates had formed throughout the
aggregation process, then a wide distribution of aggregate
sizes would have been observed. The modelling of the aggre-
gation kinetics was further simplified by considering two
limiting cases: unfolding limited aggregation and association-
limited aggregation. Both were tried and association-limited
aggregation was found to be the most appropriate as it gave
a better fit to the experimental data and more reasonable
kinetic values in comparison to previous work [33, 34].
In the case of association-limited aggregation, step a is
more rapid than step c, (𝑘
1
and 𝑘
2
≫ 𝑘
4
). As such, 𝑁
and 𝐼 come to pseudoequilibrium, hence 𝑘
1
𝐶
𝑁
≈ 𝑘
2
𝐶
𝐼
.
The total monomer concentration, 𝐶
𝑀
, is the sum of the
concentrations of the monomers in the native state (𝑁) and
the structurally altered state (𝐼), that is, 𝐶
𝑀
= 𝐶
𝑁
+ 𝐶
𝐼
.
Combining these two relationships gives
𝐶
𝑀
=
(1 + 𝐾)𝐶
𝐼
𝐾
, (5)
where𝐾 is the equilibrium constant,𝐾 = 𝑘
1
/𝑘
2
. Since step c is
the rate limiting step, the resulting kinetic model is a second-
order rate equation, which incorporates the equilibrium
constant in order to be stated in terms of 𝐶
𝑀
,
(−𝑟
𝑀
) =
𝑘
4
𝐶
𝑀
𝐶
𝐴
𝐾
(1 + 𝐾)
. (6)
As stated previously, the aggregate concentration, 𝐶
𝐴
, is
expected to have been reasonably constant; therefore, the
model can be reduced to pseudo-first order (7), where the
equilibrium constant is incorporated into the rate constant
for the rate equation (8) as follows:
(−𝑟
𝑀
) = 𝑘pseudo 𝐶𝑀, (7)
𝑘pseudo =
𝑘
4
𝐶
𝐴
𝐾
(1 + 𝐾)
. (8)
Thismodelwas subsequently used to estimate the aggregation
kinetics of all samples using the experimental particle diam-
eter, 𝑑(𝑡), (Figure 5) to calculate the number of monomers in
each aggregate as a function of time (𝐴
𝑁
(𝑡)) from the ratio of
the monomer volume to aggregate volume via
A
𝑁
(𝑡) =
𝜋[𝑑 (𝑡)]3
6𝑉
𝑀
. (9)
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(a) (b)
Figure 3: rPA aggregates formed after incubation at 47∘C for 16 hours: (a) optical micrograph, 10x magnification (170 𝜇m scale bar), and (b)
ESEMmicrograph taken with a sample temperature of 5∘C, 6 torr chamber pressure, and 30 kV electron gun accelerating voltage (10𝜇m scale
bar).
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Figure 4: (a) Change in UV light scattering arising from the growth of rPA aggregates at 45∘C, spectra collected in 10-minute intervals for
0–200 minutes, and (b) aggregate diameters calculated from light scattering spectra as a function of time.
The volume of a PAmolecule (𝑉
𝑀
) was taken to be 95.74 nm3,
which was obtained using the crystal structure, as described
previouslt. The free monomer concentration versus time
(𝐶
𝑀
(𝑡)) was obtained by taking the difference between the
initial monomer concentration (𝐶
𝑀0
) and the amount of
monomers in the aggregates, based on the previous assertion
that the aggregate concentration remained constant,
C
𝑀
(𝑡) = 𝐶
𝑀0
− [𝐶
𝐴
× 𝐴
𝑁
(𝑡)] . (10)
The final size of aggregate that the function converges on is
assumed to be the size where aggregates would have stopped
growing if the clustering process is not interfered with the
particulate growth phase. As such, this is the point at which
all the protein monomers would have been consumed and
all the proteins would have been present in the form of
the particulate aggregates. The aggregate concentration is
therefore given by;
𝐶
𝐴
=
𝐶
𝑀0
6𝑉
𝑀
𝜋 (𝑑
𝑓
)
3
. (11)
This procedure was used to generate concentration versus
time profiles for the best fit pseudo first order kinetics over
a range of temperatures, and the results for the 0.25M urea
samples are shown in Figure 7(a), and the values for the
second-order 𝑘’s are provided in Figure 7(b). It is evident
that in each case the fitted data are in good agreement with
those obtained experimentally and themagnitudes of the rate
8 Journal of Biophysics
Table 2: Changes in enthalpy (Δ𝐻), entropy (Δ𝑆), Gibbs free energy (Δ𝐺) at 25∘C, and denaturation temperature (𝑇
𝑚
) for rPA unfolding
(𝑁 ↔ 𝐼) with and without 0.25M urea.
Δ𝐻/kJmol−1 Δ𝑆/kJmol−1 K−1 Δ𝐺 at 25∘C/kJmol−1 𝑇
𝑚
(Δ𝐺 = 0)/∘C
rPA without additive 975.8 ± 40.5 3.02 ± 0.13 76.1 50.2
rPA with 0.25M urea 949.7 ± 94.6 2.92 ± 0.30 77.7 51.6
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Figure 5: Comparison of aggregate diameter calculated from light
scattering spectra versus time for rPA samples with 0.25M urea held
isothermally at various temperatures (the inset highlights higher
temperature runs).
constants obtained from these data are reasonable, although
a little high, compared to those reported elsewhere for
the association-limited aggregation of protein (e.g., bovine
granulocyte colony-stimulating factor) [33]; extracted values
were in the region of 104 to 106 dm3mol−1 s−1 over a similar
temperature range. It is clear from Figure 7(b) that the
association-limited aggregation rate constants for samples
with and without added urea increase exponentially with
temperature. On average the rate constant increases three-
fold for every 1∘C incre ase. If the data are re-plotted as
ln 𝑘 versus 1/𝑇 (Figure 7(c)), it is clear that the data follows
Arrhenius’ Law, 𝑘 = 𝐴
𝑓
exp(−𝐸act/𝑅𝑇), where𝐴𝑓 is the pre-
exponential factor, 𝑇 is the absolute temperature (𝐾), 𝐸act is
the activation of the reaction (Jmol−1) and 𝑅 is the ideal gas
constant (Jmol−1 K−1). From the gradients of each slope the
activation energies for the two sample types were calculated
to be 942.0 ± 92.4 kJmol−1 for rPA without additives and
928.8 ± 32.5 kJmol−1 for rPA with 0.25M urea. These values
suggest that the addition of urea reduced the activation
energy slightly, which correlates with the observation that
the presence of urea increases the rate of aggregation. The
magnitude of these activation energies are reasonable com-
pared to those reported elsewhere for the association limited
aggregation of protein [12]; reported as being between ∼420
and ∼840 kJmol−1. These values are reported as “observed”
activation energies and are accompanied by the suggestion
that the temperature dependence of association limited rate
constants does not follow true Arrhenius behaviour [12].
The frequency factors, 𝐴
𝑓
, for the two sample types were
calculated to be 1.8 × 10161 dm3mol−1 s−1 for rPA without
additives and 4.7 × 10158 dm3mol−1 s−1 for rPA with 0.25M
urea. These values are very high and unlikely to have any
physical significance. Published values of the second-order
frequency factors for various small molecule solution phase
reactions are in the range of 102 to 1016 dm3mol−1 s−1 [35].
This suggests that the Arrhenius equation is no more than an
empirical fit to the data here.This is not unexpected given the
suggestion cited previously that the temperature dependence
of association-limited rate constants does not follow true
Arrhenius behaviour. However, the correlation coefficients
between the data and the lines of the best fit show a reasonable
fit: 0.963 for the samples without additives and 0.973 for the
samples with 0.25M urea.
An alternative and more appropriate approach to mod-
elling the temperature dependence of the rate constant is
to factor in the behaviour of the equilibrium constant, 𝐾.
The analysis using the association-limited model has so far
yielded an “observed” second-order rate constant for the
aggregation process. The kinetic model for this analysis is
represented by
(−𝑟
𝑀
) = 𝑘obs 𝐶𝑀𝐶𝐴, (12)
where 𝑘obs is the observed rate constant. Comparing this with
(6) reveals how 𝑘obs is related to the actual rate constant (𝑘4)
and the equilibrium constant𝐾,
𝑘obs =
𝑘
4
𝐾
(1 + 𝐾)
. (13)
The temperature dependence of 𝐾 is given by [35]
ln (𝐾) = Δ𝑆
𝑅
−
Δ𝐻
𝑅𝑇
, (14)
where Δ𝑆 is the entropy change (Jmol−1 K−1), Δ𝐻 is the
enthalpy change for the process (Jmol−1), 𝑇 is the absolute
temperature (K), and 𝑅 is the gas constant (Jmol−1 K−1).
To fit the experimental data to the temperature dependence
of the equilibrium constant, it was assumed that the rate
constant, 𝑘
4
, is independent of temperature. The physical
significance of this is that the activation energy is assumed
to be negligible for the process of perturbed monomers
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Figure 6: Schematic representing the 4 possible steps in the proposed kinetic model of rPA aggregation: (a) structural perturbation, (b) initial
aggregate formation, (c) aggregate growth, and (d) aggregate clustering.
being added to the growing aggregate. This is a reasonable
assumption, since the activation energies for the reaction of
highly reactive free radicals can be close to zero [35, 36],
and given that the perturbed monomers will have highly
unfavourable hydrophobic patches exposed to water, they too
are likely to be highly reactive and easily associated with an
aggregate in order to reduce their free energy. Rearranging
(13) and equating it to (14) yields
ln(
𝑘obs
𝑘
4
− 𝑘obs
) =
Δ𝑆
𝑅
−
Δ𝐻
𝑅𝑇
. (15)
Therefore, plotting ln(𝑘obs/(𝑘4 − 𝑘obs)) versus 1/𝑇 will yield
a straight line, the gradient of which will be −Δ𝐻/𝑅 and
the intercept Δ𝑆/𝑅. The value of 𝑘
4
was found by searching
for the best fit. The initial estimate for 𝑘
4
was picked by
choosing a value greater than the largest value of 𝑘obs so that
the logarithmic term could be satisfied.When the 0.25Murea
data was plotted, it was found that the correlation coefficient
for the fit between the line of the best fit and the data
points improved as the value of 𝑘
4
was increased. Eventually,
there was no change in the correlation coefficient as 𝑘
4
was
increased. It was on this basis that an optimum value of
5.77 × 109 dm3mol−1 s−1 was selected for 𝑘
4
. The value of 𝑘
4
effectively represents the value of the frequency factor, since
the activation is assumed to be zero. As such, this optimum
value of rate constant/frequency factor is muchmore likely to
have a physical significance, since it is comparable to general
values of the frequency factor found in the literature [35]
discussed previously. The same value of 𝑘
4
was used for the
analysis of both sets of data: rPA without additives and rPA
with 0.25M urea. This was done on the assumption that
the collision rate would not be significantly altered in the
presence or the absence of urea. A plot of the resulting data is
shown in Figure 8. It is clear that the correlation coefficients
between the data and the lines of the best fit are in reasonable
agreement for both sets of samples.Δ𝐻 andΔ𝑆were extracted
from the graph for each sample and used to calculate the
Gibbs free energy change, Δ𝐺, at 25∘C. The values obtained
(Table 2) were compared reasonably well with those reported
in the literature for the Δ𝐺 between folded and unfolded
proteins, reported to typically be between 20 and 60 kJmol−1
[37].These values also indicate, as expected, that the presence
of urea reduces the stability of rPA, most likely by helping to
disrupt the native structure of the protein [4], causing it to
become perturbed at temperatures lower than those in the
absence of any urea.
To explore the effect of temperature on the extent of
disruption of individual proteins, the fraction of protein in
the perturbed intermediate state,𝑋, was calculated using (16)
and plotted as a function of temperature (Figure 9):
X = 𝐶𝐼
𝐶
𝑀
=
𝐾
(1 + 𝐾)
. (16)
Extrapolation of this data to ambient temperatures shows that
the fraction of protein in the perturbed state is negligible
at low temperatures. For example, extrapolation to 25∘C
for the sample with 0.25M urea shows that the fraction of
protein in the perturbed state is 10−14. This corroborates our
experimental observations that rPAdoes not showobservable
aggregation over extended periods (circa 16 hours) at ambient
temperature. The unfolded fraction has also been extrapo-
lated to higher temperatures, using (11) and (12), and the
results have been shown by the extrapolated line of the best
fit in Figure 9. The inset of Figure 9 shows that the fraction
of monomer in the perturbed state rises sigmoidally between
46∘C and 55∘C and that a higher proportion of protein is per-
turbedwhen urea is present. Both observations correlate with
the susceptibility of the protein samples to aggregate, that is,
the more protein perturbed, the higher the chances and the
faster the kinetics of aggregation. It also links in well with
other studies on the thermal unfolding of rPA. For example,
8-anilino-1-naphthalene sulfonate (ANS) and rPA reported
elsewhere show that the hydrophobicity of rPA increases
sigmoidally versus the temperature between 40∘ and 55∘C
[38], as was also the case when the thermal unfolding was
examined by circular dichroism, which revealed a sigmoidal
increase in unfolding versus the temperature between 45∘ and
55∘C [31].
4. Conclusions
The susceptibility of a biopharmaceutical protein rPA to
aggregate as a function of temperature and formulation
conditions has been determined, and the kinetics and ther-
modynamics of the aggregation process have been modelled
and quantified. Visual and turbidity experiments showed
that the thermal aggregation of rPA occurs at incubation
temperatures ≥43∘C, which is close to its denaturation tem-
perature. Under these conditions, the protein is likely to have
increased translational kinetic energy, hence more collisions
will take place, and also be at least partially unfolded, hence, it
has some exposed hydrophobic regions which are known to
10 Journal of Biophysics
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Figure 7: (a) Monomer concentration as a function of time for rPA samples with 0.25M urea held isothermally at various temperatures (the
inset highlights higher temperature runs). (b) Second-order association-limited aggregation rate constant versus temperature. (c) Arrhenius
plot.
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Figure 8: Natural log of equilibrium constant versus the reciprocal
of absolute temperature for the association-limited aggregation
model.
induce rapid and nonspecific aggregation. Such aggregation
was found to proceed in a stepwise manner, by first forming
spherical microscopic particles followed by clustering to
form fractal aggregates. Increasing the temperature more
than 43∘C increased the rate of aggregation dramatically and
also the size of the diameter of the spherical microscopic
particles formed from ∼360 to 500 nm when increasing the
temperature from 43∘ to 49∘C. We went on to show that
the growth of the microscopic particles can be monitored
using UV-LSS. In particular, we used the increase in scattered
light from the sample over time to elucidate aggregate size
versus time, giving a quantitative measure of the aggregation.
Moreover, the experiments were conducted over a range of
temperatures, with and without 0.25M urea, and as such, the
results were analysed to determine the rate constant and the
temperature dependence of the thermal aggregation process.
Based on this analysis, we proposed that the aggregation
process is association limited and that the temperature
dependence relates to the equilibrium behaviour between
native and perturbed states. We were also able to extract
the thermodynamic parameters for aggregation in samples
with and without urea, and these indicated that the presence
of urea reduces the stability of rPA, hence increases its
susceptibility to aggregation. The modelling tools developed
here for analysis of data from the easily accessible UV-LSS
technique provides a fast between in situ analysis method for
comparing the stability of different formulations of protein
when exposed to different environmental conditions. This
method has an important speed advantage over other light
scattering techniques when analysing such particle growth
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Figure 9: Fraction of monomer in the perturbed state as a func-
tion of temperature for the association-limited aggregation model.
Curves of the best fit follow (14) and (16) with ΔH and ΔS values
from Table 2 (black curve) on logarithmic scale (the inset shows
extrapolation to higher temperatures on normal scale).
kinetics. This work, therefore, provides a basis for quantita-
tively exploring the effect of additives and/or different pro-
cessing conditions on the rate of aggregation of industrially
relevant biopharmaceuticals with the aim of minimising any
self-association during production, downstream processing,
or storage.
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